Table 4 Continuation of the miRNA expression and prognostic factors of ccRCC

Low (n = 18)

43.39(89.17)

65.14(65.16)

159.44(171.94)

Intermediate (n = 29)

58.51(98.63)

110.15(141.57)

90.68(85.67)

High n = 9

563.01(1128.21)

202.94(270.20)

123.81(100.46)

P

0.01 ^b

0.23^b

0.31^b

Size ≥7 cm (n = 30)

57.91(97.01)

79.23(68.51)

125.34(140.61)

Size <7 cm (n = 26)

162.81(545.59)

139.51(196.72)

102.81(92.03)

P

0.36^a

0.766

0.58^a

MVI absent (n = 44)

55.97(95.09)

93.38(127.07)

119.47(126.44)

MVI present (n = 12)

355.35(899.73)

173.31(213.58)

94.63(90.02)

p

0.53^a

0.17^a

0.17^a

Fuhrman’s Grade I e II (n = 32)

56.44(99.57)

103.91(158.18)

135.37(152.50)

Fuhrman’s Grade III e IV (n = 24)

169.48(557.25)

113.84(143.83)

101.01(92.55)

P

0.33^a

0.83^a

0.40^a

pT1–2 (n = 26)

48.99(94.76)

67.86(60.49)

115.03(103.12)

pT3–4 (n = 30)

161.87(521.68)

143.33(187.99)

115.59(136.84)

P

0.33^a

0.11^a

0.98^a

Metastasis Absent (n = 48)

119.99(0.47)

117.25(5.12)

109.83(122.37)

Metastasis Present (n = 8)

50.56(114.07)

54.21(43.87)

149.38(113.15)

p

0.66^a

0.38^a

0.50^a